Phase behaviour of solutions of monoclonal antibodies
Our work is to study the phase behaviour of monoclonal antibodies (mAbs). Subcutaneous injection of monoclonal antibodies is the preferred administration, which requires high concentration formulations. However, monoclonal antibodies may undergo aggregation, reversible self-assembly and liquid-liquid phase separation at high concentrations which lead to problems in the formulation and may trigger
